These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12506779)

  • 1. Outcome assessment in the adult and juvenile idiopathic inflammatory myopathies.
    Rider LG
    Rheum Dis Clin North Am; 2002 Nov; 28(4):935-77. PubMed ID: 12506779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies.
    Miller FW; Rider LG; Chung YL; Cooper R; Danko K; Farewell V; Lundberg I; Morrison C; Oakley L; Oakley I; Pilkington C; Vencovsky J; Vincent K; Scott DL; Isenberg DA;
    Rheumatology (Oxford); 2001 Nov; 40(11):1262-73. PubMed ID: 11709610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining Clinical Improvement in Adult and Juvenile Myositis.
    Rider LG; Giannini EH; Harris-Love M; Joe G; Isenberg D; Pilkington C; Lachenbruch PA; Miller FW;
    J Rheumatol; 2003 Mar; 30(3):603-17. PubMed ID: 12610824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical assessment in adult onset idiopathic inflammatory myopathy.
    Sultan SM
    Curr Opin Rheumatol; 2004 Nov; 16(6):668-72. PubMed ID: 15577602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies.
    Huber AM; Feldman BM; Rennebohm RM; Hicks JE; Lindsley CB; Perez MD; Zemel LS; Wallace CA; Ballinger SH; Passo MH; Reed AM; Summers RM; White PH; Katona IM; Miller FW; Lachenbruch PA; Rider LG;
    Arthritis Rheum; 2004 May; 50(5):1595-603. PubMed ID: 15146430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes and disease activity measures for assessing treatments in the idiopathic inflammatory myopathies.
    Oddis CV
    Curr Rheumatol Rep; 2005 Apr; 7(2):87-93. PubMed ID: 15760586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approaches to the assessment and treatment of the idiopathic inflammatory myopathies.
    Miller FW
    Ann Rheum Dis; 2012 Apr; 71 Suppl 2():i82-5. PubMed ID: 22460145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on outcome assessment in myositis.
    Rider LG; Aggarwal R; Machado PM; Hogrel JY; Reed AM; Christopher-Stine L; Ruperto N
    Nat Rev Rheumatol; 2018 May; 14(5):303-318. PubMed ID: 29651119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on the assessment of children with juvenile idiopathic inflammatory myopathy.
    Huber AM
    Curr Rheumatol Rep; 2010 Jun; 12(3):204-12. PubMed ID: 20425522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-Reported Outcomes in Adult Idiopathic Inflammatory Myopathies.
    DiRenzo D; Bingham CO; Mecoli CA
    Curr Rheumatol Rep; 2019 Nov; 21(11):62. PubMed ID: 31741079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations.
    Ernste FC; Reed AM
    Mayo Clin Proc; 2013 Jan; 88(1):83-105. PubMed ID: 23274022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OMERACT 2018 Modified Patient-reported Outcome Domain Core Set in the Life Impact Area for Adult Idiopathic Inflammatory Myopathies.
    Regardt M; Mecoli CA; Park JK; de Groot I; Sarver C; Needham M; de Visser M; Shea B; Bingham CO; Lundberg IE; Song YW; Christopher-Stine L; Alexanderson H
    J Rheumatol; 2019 Oct; 46(10):1351-1354. PubMed ID: 30770504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.
    Isenberg DA; Allen E; Farewell V; Ehrenstein MR; Hanna MG; Lundberg IE; Oddis C; Pilkington C; Plotz P; Scott D; Vencovsky J; Cooper R; Rider L; Miller F;
    Rheumatology (Oxford); 2004 Jan; 43(1):49-54. PubMed ID: 12867580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-reported outcomes and adult patients' disease experience in the idiopathic inflammatory myopathies. report from the OMERACT 11 Myositis Special Interest Group.
    Alexanderson H; Del Grande M; Bingham CO; Orbai AM; Sarver C; Clegg-Smith K; Lundberg IE; Song YW; Christopher-Stine L
    J Rheumatol; 2014 Mar; 41(3):581-92. PubMed ID: 24429182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group.
    Lovell DJ; Lindsley CB; Rennebohm RM; Ballinger SH; Bowyer SL; Giannini EH; Hicks JE; Levinson JE; Mier R; Pachman LM; Passo MH; Perez MD; Reed AM; Schikler KN; Smith M; Zemel LS; Rider LG
    Arthritis Rheum; 1999 Oct; 42(10):2213-9. PubMed ID: 10524696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of disease activity and its sequelae in children and adults with myositis.
    Rider LG
    Curr Opin Rheumatol; 1996 Nov; 8(6):495-506. PubMed ID: 9018452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International consensus on preliminary definitions of improvement in adult and juvenile myositis.
    Rider LG; Giannini EH; Brunner HI; Ruperto N; James-Newton L; Reed AM; Lachenbruch PA; Miller FW;
    Arthritis Rheum; 2004 Jul; 50(7):2281-90. PubMed ID: 15248228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancing the Development of Patient-reported Outcomes for Adult Myositis at OMERACT 2016: An International Delphi Study.
    Park JK; Mecoli CA; Alexanderson H; Regardt M; Christopher-Stine L; Casal-Domínguez M; de Groot I; Sarver C; Lundberg IE; Bingham CO; Song YW
    J Rheumatol; 2017 Nov; 44(11):1683-1687. PubMed ID: 28765245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical assessment in juvenile idiopathic inflammatory myopathies and the development of disease activity and damage tools.
    Pilkington C
    Curr Opin Rheumatol; 2004 Nov; 16(6):673-7. PubMed ID: 15577603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proposal for a Candidate Core Set of Fitness and Strength Tests for Patients with Childhood or Adult Idiopathic Inflammatory Myopathies.
    van der Stap DK; Rider LG; Alexanderson H; Huber AM; Gualano B; Gordon P; van der Net J; Mathiesen P; Johnson LG; Ernste FC; Feldman BM; Houghton KM; Singh-Grewal D; Kutzbach AG; Alemo Munters L; Takken T;
    J Rheumatol; 2016 Jan; 43(1):169-76. PubMed ID: 26568594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.